
Senti Biosciences fell 90.6% from $1.45 to $0.14, behind the S&P 500's +11.2%. Its worst day was Jul 15 (−39.7%), and its low came Nov 16 at $0.14.
Nov 17, 2025 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Senti Biosciences shares rose 17.9%, while the S&P 500 fell 0.8%.
+17.9%, the year's best day · S&P 500 −0.8%
Senti Biosciences closed at its highest level of the year, 64.8% above where the year started.
Story events cover the past 12 months · Times ET
+12.2% · S&P 500 −0.3%
EPS of $-0.53 missed the $-0.46 estimate on $22,000.00 revenue (est. $500,000.00).
−10.4% · S&P 500 −1.7%
EPS of $-0.14 beat the $-0.34 estimate on $16,000.00 revenue.
+8.0% · S&P 500 +0.8%
Senti Biosciences shares rose 16.8%, while the S&P 500 fell 0.0%.
+16.8% · S&P 500 0.0%
Senti Biosciences shares fell 39.7%, while the S&P 500 rose 0.4%.
−39.7%, the year's worst day · S&P 500 +0.4%
EPS of $-0.41 missed the $-0.28 estimate on $17,000.00 revenue.
−4.2% · S&P 500 −0.5%
Senti Biosciences shares fell 20.0%, while the S&P 500 fell 0.0%.
−20.0% · S&P 500 0.0%
Senti Biosciences shares fell 23.9%, while the S&P 500 fell 1.8%.
−23.9% · S&P 500 −1.8%
Where it ended: a close of $0.14 on Nov 16, 2026. Up next: Q3 2026 earnings on Dec 1, 2026 (EPS est. $-0.31).
Nothing in the past 12 months.
All SNTI dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SNTI and SPY from Benzinga historical bars. Not investment advice.